AstraZeneca shares rise following positive quarterly results

AstraZeneca shares experienced a significant upward trend, with one report noting a 7.02% increase to $186.65. This movement follows the release of positive quarterly earnings.

Technical analysis indicates the stock has broken above its 200-day moving average, signaling a recovery from previous lows. While the stock shows strong buying pressure, indicators such as the RSI14 suggest it is currently in overbought territory. Key resistance levels are identified near 140.78–140.86 GBP, with potential targets reaching previous all-time highs if current momentum is sustained.